Simvastatin in the treatment of primary hyperlipidemia type IIA: Eficacy, safety and tolerability of 10, 20 and 40 mg/day
A. Sussekov, M. Tvorogova, E. Solovieva, T. Rozhkova, V. Titov, V. KukharchukVolume:
144
Year:
1999
Language:
english
DOI:
10.1016/s0021-9150(99)80731-x
File:
PDF, 122 KB
english, 1999